During childhood, the quiescent phase of testicular activity, the hCG stimulation test is widely used to evaluate testicular function. Inhibin B, a gonadal peptide regulating FSH secretion, is an established marker of Sertoli cell function and spermatogenesis in adults. In contrast to the other hormones of the hypothalamo-pituitarygonadal axis, inhibin B is also secreted in detectable amounts during childhood. The aim of this study was to determine whether basal inhibin B levels are able to predict prepubertal testicular function, so as to avoid a stimulation test. Inhibin B and testosterone before and after hCG stimulation were measured in 54 male children with various testicular disorders by an immunoassay specific for inhibin B. Basal inhibin B was compared to the testosterone increase after hCG. Inhibin B and the hCG-induced testosterone increment correlated strongly (r ϭ 0.84; P Ͻ 0.0001). Patients with anorchia were clearly distinguishable from those with abdominal testes, having undetectable (inhibin B, Ͻ 15 pg/mL) respective normal inhibin B levels for age. Inhibin B and the testosterone response to hCG were low in boys with testicular damage (delayed diagnosis of cryptorchidism; after testicular torsion) and in patients with gonadal dysgenesis, but were normal or increased in children with androgen insensitivity syndrome. We conclude that basal inhibin B predicts the testosterone response to hCG in boys and therefore gives reliable information about both the presence and function of the testes. The diagnostic procedure in cryptorchidism may be reduced to a single inhibin B measurement. Furthermore, inhibin B levels show specific alterations in patients with sexual ambiguity, adding a valuable diagnostic tool to the complex differential diagnosis of male pseudohermaphroditism. (J Clin Endocrinol Metab 85: 134 -138, 2000) 
T HE EVALUATION of testicular function by basal rou-
tine hormone assay is easy in infants until the age of 3-4 months, in pubertal boys (1) (2) (3) (4) , and in adult men. In boys between infancy and puberty it remains difficult due to the low activity of the hypothalamo-pituitary-testicular axis. The response of testosterone to hCG has long been used successfully to evaluate the presence or absence of testicular tissue and to elucidate defects of testosterone biosynthesis or action (5) (6) (7) (8) . However, it remains an uncomfortable stimulation test. Basal levels of Sertoli cell products such as Mullerian inhibiting substance (9) or inhibin B (10, 11) are measurable during childhood without previous stimulation. Mullerian inhibiting substance was found to be a good marker for the presence and integrity of testicular tissue (9, 12) , but is not yet used for routine purposes. Inhibin is a dimeric gonadal peptide hormone that suppresses FSH secretion of the pituitary and thus plays an important role in the feedback regulation of the pituitary-gonadal axis. Recent highly specific immunoassays discriminate between the two biologically active isoforms, inhibin A and B (13, 14) . In the male, inhibin B is the principle circulating form and is accepted as a marker of Sertoli cell function and spermatogenesis (15) (16) (17) (18) (19) (20) in adults. In prepubertal boys, inhibin B levels have been found to be age related (10, 11) . Roughly, inhibin B follows the age-related pattern of testosterone, with a peak at about 3-6 months of age. Values within the normal range for adult men can be observed up to the age of 2 yr (10, 11). The present study was undertaken to compare the value of basal inhibin B determinations with hCG stimulation tests in the prediction of prepubertal testicular function.
Subjects and Methods Subjects
We studied 54 males ranging in age from 1 month to 16.8 yr. Karyotypes were 46,XY (n ϭ 48); 45,X0/46,XY (n ϭ 3); 47,XXY/45,X0 (n ϭ 1); and 46,XX (n ϭ 2). The patients had been referred to the Departments of Pediatrics and Divisions of Endocrinology at the Universities of Zurich (Switzerland), Bonn, Heidelberg, Lubeck, and Cologne (Germany) for hormonal evaluation of gonadal function, including a hCG stimulation test. The patients were divided into 3 subgroups depending on their clinical presentation (Table 1) : group I, patients with normal phallus but nonpalpable testes or suspicious testicular function (n ϭ 21); group II, patients with anomaly of the phallus but palpable testes (n ϭ 16); and group III, patients with anomaly of the phallus and nonpalpable testes (n ϭ 17). The final diagnoses of 42 patients after work-up are shown in Table 1 . In 4 patients the parents refused further evaluation. All patients were clinically prepubertal, and testicular volume, if palpable, was less than 3 mL.
hCG test
The basal blood samples were obtained in the morning, followed by a single im injection of 5000 IE hCG/m 2 body surface area. Seventy-two hours later, a second sample was taken. Plasma was stored at Ϫ20 to Ϫ80 C until analysis.
Testosterone, inhibin B, FSH, and LH were measured before hCG administration; testosterone and inhibin B were measured after hCG administration. An increment in plasma testosterone (⌬ testosterone) of more than 0.8 ng/mL or an absolute level greater than 0.9 ng/mL after hCG treatment were considered to indicate the presence of functioning testicular tissue and were defined as normal (21) .
Hormonal assays
Serum inhibin B was measured in duplicate by a previously described (13) enzyme-linked immunoabsorbent assay (Serotec, Kidlington, UK) using two different antibodies directed against distinct epitopes on the ␣-and ␤-subunits. The detection limit was 15 pg/mL; the inter-and intraassay coefficients of variation were 14.2% and 4.6%, respectively. Reference values (median and 5th-95th percentile) for inhibin B are based on 143 healthy, prepubertal German boys (our unpublished data) and are comparable to the data reported by Andersson et al. (10, 11) . Testosterone, FSH, and LH were measured by a commercially available enzyme immunoassay (Roche Molecular Biochemicals, Mannheim, Germany). The detection limits were: testosterone, 0.02 ng/mL; FSH, 0.1 U/L; and LH, 0.1 U/L.
Statistical analysis
The changes in testosterone before and after hCG treatment were compared using the Wilcoxon test. The testosterone increment after hCG was expressed as ⌬ testosterone, Spearman rank correlation coefficients were calculated between ⌬ testosterone and basal inhibin B, basal FSH, and basal LH. Inhibin B levels before and after hCG administration were compared by paired t test, as they were normally distributed (Kolmogorow-Smirnov test). Inhibin B levels below the detection limit were set at 15 pg/mL.
Each individual inhibin B level was assigned to an age-dependent subgroup (subgroup 1, 0 -6 months; subgroup 2, 6 months to 2 yr; subgroup 3, 2 yr until puberty), and individual inhibin B sd scores according to these subgroups were calculated.
All statistical analyses were performed using SPSS, Inc., software (SPSS, Inc., Chicago, IL), version 7.5 for Windows.
Results
Only a weak correlation was found between basal inhibin B and basal testosterone levels (r ϭ 0.35; P Ͻ 0.05), but basal inhibin B and the testosterone increment after hCG (⌬ testosterone) correlated strongly (r ϭ 0.84; P Ͻ 0.0001; Fig. 1 ). The median testosterone increase was 1.26 ng/mL (range, 0.00 -13.2). Inhibin B before hCG (median, 95 pg/mL; range, 10 -703) and after hCG (106 pg/mL; 10 -600) did not differ significantly.
To eliminate age-dependent variations in inhibin B values, the sd scores for individual inhibin B levels were calculated. The correlation between inhibin B sd score and ⌬ testosterone remained very strong (r ϭ 0.77; P Ͻ 0.0001). The relationship between individual inhibin B sd scores and final diagnoses is shown in Fig. 2 .
Patients with anorchia were clearly separated from those with abdominal testes; they had undetectable respective normal inhibin B and ⌬ testosterone The mean inhibin B sd scores were Ϫ1.98 and Ϫ0.8, respectively (P Ͻ 0.0038). In patients with androgen resistance, inhibin B levels and ⌬ testosterone were normal (n ϭ 3) or elevated (n ϭ 4) for age (mean inhibin B sd score, 1.78; ⌬ testosterone: median, 6.7 ng/mL; range, 1.3-13.2 ng/mL). Five patients with male pseudohermaphroditism and known tubular involvement (gonadal dysgenesis) had inhibin B levels below the fifth percentile (mean inhibin B sd score, Ϫ1.73), but in three of them the testosterone response to hCG was normal (⌬ testosterone, 1.3, 1.96 and 3.3 ng/mL). Testicular damage (testicular torsion, orchiopexy, testicular trauma) was invariably followed by inhibin B values below the fifth percentile and insufficient ⌬ testosterone (mean inhibin B sd score, Ϫ1.98). Two patients with the XX-male syndrome had inhibin B and ⌬ testosterone levels normal for age. In most patients a clear correlation between inhibin B levels and ⌬ testosterone could be demonstrated, but seven children had diverging results: three patients with gonadal dysgenesis (aged 3 months) had a normal testosterone response to hCG but inhibin B levels below the fifth percentile (inhibin B, 86, 86, and 103 pg/ mL), one patient with cryptorchidism had low ⌬ testosterone (0.53 ng/mL), but inhibin B levels within the normal range for age (69 pg/mL), and three patients with LH receptor defect presenting with hypospadias (n ϭ 2) and ambiguous genitalia (n ϭ 1) had no testosterone increase after hCG, but inhibin B levels were within the lower normal range for age (inhibin B sd scores, 71 (Ϫ1.05); 62 (Ϫ0.75), and 110 (Ϫ0.54) pg/mL; see Table 2 ).
Discussion
Our results in infants and prepubertal boys with various testicular disorders demonstrate a strong correlation between basal inhibin B levels and the hCG-induced testosterone increment. This observation is of important practical interest considering that a single inhibin B measurement gives enough reliable information about the presence or absence of testes, obviating the need for a more invasive hCG test in the work-up of cryptorchidism. As inhibin B levels are age dependent, reference values for age have to be taken into account.
Our data differ from previous reports in two aspects: 1) although we found no influence of hCG stimulation or inhibin B levels, earlier studies in young adults have reported an increment (22, 23) ; and 2) although we found very low inhibin B levels in cases with anorchia or testicular dysgenesis, earlier reports found no differences in comparison with normal boys (24) . These discrepancies are most likely due to the previously used, less specific and sensitive inhibin assays cross-reacting with free ␣-subunits (25) .
Whereas basal inhibin B thus can be used as a general marker of testicular presence and function in boys with absent, insufficient, or normal tubular tissue, the situation may be different in patients with some specific conditions. In our five patients with testicular dysgenesis basal inhibin B levels were low, whereas the testosterone response to hCG was normal in three of them, suggesting that tubular function is more severely affected than Leydig cell function. On the other hand, in patients with defects of testosterone biosynthesis, Leydig cell aplasia, or LH receptor defect, one would expect normal inhibin B levels, whereas the testosterone response to hCG would be absent or low. This was indeed the case in three patients with LH receptor defect.
It remains unclear why some prepubertal patients with androgen resistance have elevated inhibin B levels in the absence of elevated peripheral FSH. A similar finding of increased levels of anti-Mullerian hormone in patients with androgen insensitivity was reported by Rey et al. (12) , suggesting an increased production of peptide hormones by Sertoli cells in these patients. As a possible explanation, androgen resistance may lead to a higher daily production rate of FSH (not reflected by basal FSH levels) due to the resistance of the gonadotropins to testosterone feedback and thus to an increase in circulating inhibin B. Alternatively, the insufficient paracrine action of testosterone on Sertoli cells (26, 27) may directly lead to an unphysiological high inhibin B production rate. In conclusion, our data demonstrate that inhibin B is a reliable indicator of the presence and absence of testes in infants and prepubertal boys. Particularly in cryptorchid boys, a single inhibin B determination may predict Sertoli and Leydig cell function, thus obviating further hormonal studies. Furthermore, inhibin B levels add a valuable tool to the differential diagnosis of sexual ambiguity, yielding low levels in global testicular disorders and normal or elevated levels in specific disorders concerning androgen biosynthesis or action. Inhibin B values below the 5th percentile, at the 50th percentile, and above the 95th percentile are represented by low, normal, and high. The reference collective is described in Subjects and Methods. Low, normal, and high ⌬ testosterone represents the individual value compared to the age-specific pattern described by Knorr et al. (21) .
